The AAPM 2020 educational program will be available in fall 2019. In the meantime browse 2019 meeting sessions and speakers to get a sense of the premier pain education offered during the AAPM Annual Meeting & Preconferences. Access recordings of past meeting sessions on demand.

Cutting Edge Science and Clinical Practice: Buprenorphine/Naloxone for Pain and Opioid Use Disorder (215)

5–6 pm Friday, March 8

Opioid use disorder (OUD) and pain often co-occur, complicating the treatment of each condition. Research relevant to the use of buprenorphine/naloxone for treatment of patients with opioid use disorder and chronic pain will be presented. Participants will learn about approaches for managing patients with OUD while effectively treating pain.

Opioid Use Disorder Cascade of Care and Adoption of Evidence-Based Practices

Kristen Huntley, PhD

The Role of Buprenorphine When Benefit No Longer Outweighs Harm of Long-Term Opioid Therapy for Chronic Pain

William Becker

Acute and Perioperative Pain Management in Patients Taking Buprenorphine

Andrew A. Herring, MD

Learning Objectives:

  • Express the complexity of diagnosing OUD in the setting of long-term opioid therapy for pain.
  • Describe appropriate treatment approaches for patients with pain and OUD.
  • Apply best practice strategies for the management of acute and perioperative pain for patients on buprenorphine/naloxone and demonstrate the uses of intravenous buprenorphine for acute and perioperative pain.